OptimizeRx Corp — Director's Dealing 2020

Jun 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2020-06-03

Reporting Person: BAKER DOUGLAS P (CHIEF FINANCIAL OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-03	Common Stock	M	17421	$3.15	Acquired	89338	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-03	Stock Option	$3.15	M	23302	Disposed	2020-06-24	Common Stock (23302)	Direct

Footnotes

F1: This Form is being filed to report the exercise of expiring stock options for a total of 23,302 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 17,421 shares of common stock.